The Israeli Ministry of Health issued a statement on the 26th that the Ministry has approved the emergency use of Paxlovid, an oral drug for the treatment of new crown produced by Pfizer in the United States, which is the first anti-new coronavirus oral drug approved by Israel for emergency use. The Israeli Ministry of Health said in a statement that the oral drug will be used to treat patients with mild to moderate COVID-19. Israel's Ministry of Health has signed a drug purchase agreement with Pfizer, which is expected to arrive in Israel in the coming days. Pfizer's anti-COVID-19 oral drug consists of two antiviral drugs that inhibit the activity of proteases necessary for the replication of the new crown virus in the human body.
![Is there a difference in the effect of the new crown strengthening injection at different ages? NEJM publishes real data on millions of people[fig]](data:image/gif;base64,R0lGODlhAQABAIAAAP///wAAACwAAAAAAQABAAACAkQBADs=)